Cafepharma Today

May 15 2025 - FDA approves Amneal's self-administered migraine treatment
FDA approves Amneal's self-administered migraine treatment
VC firm reveals plan for 30K-square-foot biotech incubator space in New Jersey
Philips taps Nvidia to build AI model for MRI
FDA delays decision on Biohaven's rare disease drug filing, plans adcomm
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

EU approves biosimilar of J&J and Merck's Remicade, WSJ says
Yahoo/Fly on the Wall
Wednesday, September 11, 2013 - 8:48am
tags:
Europe, biosimilars, JNJ, Merck, Remicade, rheumatoid arthritis
Novo Nordisk Pushes Ahead In Challenging Year
Investors.com
Tuesday, September 10, 2013 - 4:48pm
tags:
Novo Nordisk, Sanofi, Bristol-Myers Squibb, diabetes, Eli Lilly, MannKind
Merck Top Scientist Plans Major Changes for Drug Research
Bloomberg
Tuesday, September 10, 2013 - 4:46pm
tags:
Merck, R&D
Theravance confirms FDA panel recommends approval of Theravance-Glaxo lung drug
Yahoo/Fly on the Wall
Tuesday, September 10, 2013 - 4:28pm
tags:
Theravance, FDA, advisory panel, COPD, GSK, Anoro Ellipta
Myelofibrosis Battle: Novartis Vs. Sanofi
Seeking Alpha
Tuesday, September 10, 2013 - 4:25pm
tags:
Novartis, Sanofi, myelofibrosis, Jakafi, Incyte, SAR302503
Is This Experimental Lung Cancer Drug Back on Track?
Motley Fool
Tuesday, September 10, 2013 - 11:55am
tags:
lung cancer, Peregrine Pharmaceuticals, bavituximab
ChemoCentryx Falls on Weak Diabetic Nephropathy Drug Data
TheStreet.com
Tuesday, September 10, 2013 - 11:37am
tags:
ChemoCentryx, diabetic nephropathy, CCX140
Can Stopping This Hedgehog Create New Cancer Treatments?
Motley Fool
Tuesday, September 10, 2013 - 11:30am
tags:
hedgehog pathway inhibitor, Curis, Roche, basal cell carcinoma, Erivedge
Busy Biogen Idec fuels Amicus in Parkinson's drug chase
Fierce Biotech
Tuesday, September 10, 2013 - 11:28am
tags:
Biogen Idec, Amicus, Parkinson's Disease
Novartis picks up its development option in $700M rare-disease pact
Fierce Biotech
Tuesday, September 10, 2013 - 11:25am
tags:
Novartis, Camarus, CAM2029, acromegaly
GlaxoSmithKline says not planning to leave China, China Daily reports
Yahoo/Fly on the Wall
Tuesday, September 10, 2013 - 11:23am
tags:
GSK, China
Medtronic seeks FDA update on all approved pacemakers and defibrillators
Mass Device
Tuesday, September 10, 2013 - 11:22am
tags:
FDA, pacemakers, defibrillators, Medtronic, devices
Glaxo Declines as FDA Clears Path for Advair Rivals
Bloomberg
Tuesday, September 10, 2013 - 10:41am
tags:
GSK, Advair, FDA, COPD, asthma, Sandoz, Actavis, Mylan, generics
FDA scientists back accelerated approval for Roche drug to treat early-stage breast cancer
Washington Post, DC
Tuesday, September 10, 2013 - 10:39am
tags:
Perjeta, FDA, Roche, breast cancer
Gorsky And J&J Employees: Phone Calls, Recalls And Distractions
Pharmalot
Tuesday, September 10, 2013 - 10:38am
tags:
Alex Gorsky, JNJ, cell phones, drug reps, Pharma CEOs
IPad-Toting Doctors Fuel Publisher Profits as Paper Fades
Bloomberg
Tuesday, September 10, 2013 - 10:33am
tags:
iPad, physicians
Forest Labs Picks Former Bausch Leader Saunders as its CEO
Bloomberg
Tuesday, September 10, 2013 - 10:27am
tags:
Pharma CEOs, Bausch & Lomb, Forest Labs, Brenton Saunders
Is Seattle Genetics an Acquisition Target?
Motley Fool
Tuesday, September 10, 2013 - 10:26am
tags:
M&A, Seattle Genetics, Adcetris, Bayer, AbbVie, Genentech
Ahold Sues Medicis, Teva, Barr, Mylan Over Acne Treatment
Bloomberg
Tuesday, September 10, 2013 - 10:24am
tags:
Medicis, Teva, Barr Laboratories, acne, Mylan, Ahold, Solodyn
Neurocrine Biosciences shares down on study
Yahoo/AP
Tuesday, September 10, 2013 - 10:22am
tags:
Neurocrine Biosciences, tardive dyskinesia

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.